References
- Rahman A, Isenberg DA. SLE. N Engl J Med 2008; 358(9)929–939
- Carneiro-Sampaio M, Liphaus BL, Jesus AA, Silva CA, Oliveira JB, Kiss MH. Understanding SLE physiopathology in the light of primary immunodeficiencies. J Clin Immunol 2008; 28(Suppl 1)S34–S41
- Suh CH, Kim HA. Cytokines and their receptors as biomarkers of SLE. Expert Rev Mol Diagn 2008; 8(2)189–198
- Lago F, Dieguez C, Gómez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007; 3(12)716–724
- Calabrò P, Limongelli G, Pacileo G, Di Salvo G, Golino P, Calabrò R. The role of adiposity as a determinant of an inflammatory milieu. J Cardiovasc Med (Hagerstown) 2008; 9(5)450–460
- Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008; 216(1)3–13
- Fantuzzi G. Adiponectin and inflammation: Consensus and controversy. J Allergy Clin Immunol 2008; 121(2)326–330
- Anato V, Garmendia JV, Bianco NE, De Sanctis JB. Antihypertensive treatment decreased serum leptin levels in severe preeclampsia during pregnancy. Ann Nutr Metab 2001; 45(5)190–192
- Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Muñoz EG, Salazar-Paramo M, González-Ortiz M, Martínez-Abundis E, Gamez-Nava JI. Serum leptin levels in women with SLE. Rheumatol Int 2002; 22(4)138–141
- Wisłowska M, Rok M, Stepień K, Kuklo-Kowalska A. Serum leptin in SLE. Rheumatol Int 2008; 28(5)467–473
- Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y, Makino H. Altered levels of adipocytokines in association with insulin resistance in patients with SLE. J Rheumatol 2006; 33(8)1545–1552